APRIL SMITH: Open Payments
NPI 1346605557 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 125 payments from 12 companies in 2025. Trend: 2023 $1,123 · 2024 $1,076 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $441 |
| Alkermes, Inc. | 35 | $301 |
| Axsome Therapeutics, Inc. | 19 | $199 |
| Otsuka America Pharmaceutical, Inc. | 12 | $180 |
| E.R. Squibb & Sons, L.L.C. | 17 | $174 |
| JAZZ PHARMACEUTICALS INC. | 7 | $116 |
| Teva Pharmaceuticals USA, Inc. | 4 | $71 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
Products named: CAPLYTA, ARISTADA, COBENFY, XYWAV, Auvelity, ABILIFY MAINTENA, REXULTI, Sunosi.
Industry payments across NE — which companies pay providers there.
